766 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABBV AbbVie Inc. $95.37 $144.42B N/A
Article Searches
7 Reasons Why Prescription Drug Prices Are Extremely Expensive https://www.fool.com/investing/2017/06/09/7-reasons-why-prescription-drug-prices-are-extreme.aspx?source=iedfolrf0000001 Jun 09, 2017 - There are myriad reasons going to the drugstore hurts the wallet.
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion) https://www.fool.com/investing/2017/06/30/the-9-best-selling-prescription-drugs-in-2016-each.aspx?source=iedfolrf0000001 Jun 30, 2017 - These prescription drugs raked in billions of dollars last year. But several of them might not be so lucrative for much longer.
3 Dividend Stocks That Investors Should Love https://www.fool.com/investing/2017/04/23/3-dividend-stocks-that-investors-should-love.aspx?source=iedfolrf0000001 Apr 23, 2017 - Want to buy great dividend stocks? Check out AbbVie, Southern Company, and Tupperware Brands.
7 Medical Conditions That Will Be Lining Big Pharma's Pockets by 2020 https://www.fool.com/investing/2017/09/06/7-medical-conditions-that-will-be-lining-big-pharm.aspx?source=iedfolrf0000001 Sep 06, 2017 - Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions.
3 High-Yield Dividend Aristocrat Stocks https://www.fool.com/investing/2017/08/28/3-high-yield-dividend-aristocrat-stocks.aspx?source=iedfolrf0000001 Aug 28, 2017 - These three high-yield dividend stocks may be worth checking out right now.
Here's the Best Dividend Stock in Big Pharma https://www.fool.com/investing/2017/09/03/heres-the-best-dividend-stock-in-big-pharma.aspx?source=iedfolrf0000001 Sep 03, 2017 - There are plenty of good dividend stocks in big pharma, but AbbVie appears to be the best of all.
These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet https://www.fool.com/investing/2017/07/23/these-5-drugs-could-be-worth-45-billion-and-theyre.aspx?source=iedfolrf0000001 Jul 23, 2017 - Biogen, Johnson & Johnson, Lilly, AbbVie, and Celgene could have huge winners on their hands in the near future.
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain https://www.fool.com/investing/2017/04/17/lilly-and-incytes-loss-is-abbvie-and-regenerons-ga.aspx?source=iedfolrf0000001 Apr 17, 2017 - The FDA has rejected Eli Lilly and Incyte's application for approval of a potential blockbuster rheumatoid arthritis drug.
Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather? https://www.fool.com/investing/2017/06/29/is-vertex-pharmaceuticals-running-out-of-steam-or.aspx?source=iedfolrf0000001 Jun 29, 2017 - Vertex stock might be down a little from its recent highs, but don't think its tremendous run is over.
Bleak Outlook for Big Drug Makers https://www.wsj.com/articles/bleak-outlook-for-big-drug-makers-1493051153?mod=rss_markets_main Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.

Pages: 123456...77

Page 1>